This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Well Characterized Biologics & Biological Assays
November 1-3, 2022
College Park Marriott Hotel & Conference CenterHyattsville, Maryland, USA

Laura Ricles
Cell Therapy Team Lead at FDA


Laura Ricles, PhD, is  a biomedical engineer and cell therapy team lead in the Office of Tissues and  Advanced Therapies (OTAT) in the Center for Biologics Evaluation and Research  (CBER) at the US Food and Drug Administration (FDA). Dr. Ricles joined OTAT as  a product reviewer of cell therapy products for clinical trial applications  and marketing. She is currently the cell therapy team lead in the Cell  Therapies Branch in OTAT. Dr. Ricles earned a B.S. in bioengineering at  Lehigh University and a Ph.D. in biomedical engineering at The University of  Texas at Austin.

Agenda Sessions

  • FDA Address: Manufacturing, Quality and Regulatory Considerations for Cell & Gene Therapies

  • Regulatory Town Hall